Cleared Traditional

K965127 - DGH MODEL 9000

K965127 is the FDA 510(k) clearance for DGH MODEL 9000 by Dgh Technology, Inc.. It is a Class 2 Ophthalmic device (product code HQC) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K965127 · Dgh Technology, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1997
Decision
84d
Days
Class 2
Risk

K965127 is an FDA 510(k) clearance for the DGH MODEL 9000. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Dgh Technology, Inc. (Exton, US). The FDA issued a Cleared decision on March 17, 1997 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dgh Technology, Inc. devices

Submission Details

510(k) Number K965127 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 1996
Decision Date March 17, 1997
Days to Decision 84 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 110d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 99
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K965127.
WELCH ALLYN PHACO ILLUMINATOR
K971750 · Welch Allyn, Inc. · Jun 1997
STORZ MICROFLOW AND STORZ STANDARD PHACOEMULSIFICATION NEEDLES
K971439 · Storz Instrument Co. · Jun 1997
AMO DIPLOMAX/OPSYS CONSOLE
K971186 · Allergan, Inc. · Jun 1997
HANDPIECE FOR NIDEK CV-12000 PHACO SYSTEM
K960287 · Nidek, Inc. · Nov 1996
STORZ D7120 PHACO HANDPIECE MAINTENANCE KIT & STORZ D7125 PHACO HANDPIECE NEEDLE WRENCH
K960024 · Storz Instrument Co. · Sep 1996
AMO PRESTIGE DAY PACK (ALLERGAN, INC.)
K962402 · Allergan, Inc. · Sep 1996